Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2017 May 23;85(6):e00212-17. doi: 10.1128/IAI.00212-17

Correction for Fletcher et al., “Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein”

Leah D Fletcher 1, Liesel Bernfield 1, Vicki Barniak 1, John E Farley 1, Alan Howell 1, Melissa Knauf 1, Peggy Ooi 1, Robert P Smith 1, Paige Weise 1, Mike Wetherell 1, Xiaoling Xie 1, Robert Zagursky 1, Ying Zhang 1, Gary W Zlotnick 1
PMCID: PMC5442624  PMID: 31305626

AUTHOR CORRECTION

Volume 72, no. 4, p. 2088–2100, 2004, https://doi.org/10.1128/IAI.72.4.2088-2100.2004. Page 2089, column 2: Lines 62–64 should read as follows. “… Oligonucleotides used for the amplification of these 2086 genes were 5LIP2996 and N2996SPH. The same oligonucleotide PCR primers were used for all five strains. The restriction site BamHI was … .”

Page 2091, Table 2: Row 18 labeled “5LIP771” should not be included in the table.


Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES